AG
LUNG icon

Algert Global’s Pulmonx LUNG Stock Holding History

Algert Global’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
98,332
+12,970
+15% +$17.9K ﹤0.01% 1216
2026
Q1 		$110K Sell
85,362
-14,350
-14% -$23.7K ﹤0.01% 1105
2025
Q4 		$220K Buy
99,712
+21,990
+28% +$41.3K ﹤0.01% 1045
2025
Q3 		$126K Buy
77,722
+54,142
+230% +$113K ﹤0.01% 1078
2025
Q2 		$61.1K Buy
+23,580
New +$93K ﹤0.01% 1153
2024
Q3 		– Sell
-20,939
Closed -$133K – 1409
2024
Q2 		$133K Sell
20,939
-36,564
-64% -$281K ﹤0.01% 1351
2024
Q1 		$533K Sell
57,503
-32,490
-36% -$381K 0.02% 760
2023
Q4 		$1.15M Sell
89,993
-27,334
-23% -$285K 0.05% 582
2023
Q3 		$1.21M Buy
117,327
+23,594
+25% +$273K 0.06% 525
2023
Q2 		$1.23M Buy
93,733
+64,420
+220% +$788K 0.05% 582
2023
Q1 		$328K Sell
29,313
-17,547
-37% -$173K 0.02% 925
2022
Q4 		$395K Buy
+46,860
New +$446K 0.02% 871
2022
Q1 		– Sell
-7,520
Closed -$241K – 1258
2021
Q4 		$241K Buy
+7,520
New +$275K 0.03% 796

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Algert Global's LUNG Position: Q2 2026 in Review

Algert Global increased its Pulmonx (LUNG) stake by 15% in Q2 2026, buying an estimated $17.9K and bringing the position to 98,332 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

Algert Global first reported a position in LUNG in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.23M in Q2 2023. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Algert Global held 98,332 shares of Pulmonx worth $128K as of Q2 2026.
  • Algert Global bought 12,970 Pulmonx shares in Q2 2026, an estimated $17.9K.
  • Pulmonx made up ﹤0.01% of Algert Global's portfolio in Q2 2026, its #1216 holding.
  • Algert Global first reported a position in Pulmonx in Q4 2021 and has held it in 13 quarters since.
  • Algert Global's Pulmonx position peaked at $1.23M in Q2 2023.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.